Agilent Technologies, Inc. $A Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 4.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 599,581 shares of the medical research company’s stock after purchasing an additional 24,687 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $82,712,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Flynn Zito Capital Management LLC boosted its position in shares of Agilent Technologies by 3.2% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after purchasing an additional 69 shares in the last quarter. Forum Financial Management LP lifted its position in Agilent Technologies by 2.5% during the 3rd quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after acquiring an additional 70 shares during the period. Gabelli Funds LLC lifted its position in Agilent Technologies by 1.1% during the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after acquiring an additional 74 shares during the period. Fiduciary Trust Co lifted its position in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after acquiring an additional 77 shares during the period. Finally, NorthCrest Asset Manangement LLC lifted its position in Agilent Technologies by 1.6% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after acquiring an additional 79 shares during the period.

Wall Street Analysts Forecast Growth

A has been the subject of a number of research reports. Wells Fargo & Company lowered their price target on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. HSBC initiated coverage on Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. UBS Group lowered their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Barclays lowered their price target on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, TD Cowen lowered their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $163.71.

Agilent Technologies Stock Performance

NYSE A opened at $118.49 on Friday. The stock has a 50-day simple moving average of $115.99 and a two-hundred day simple moving average of $131.97. The firm has a market capitalization of $33.49 billion, a P/E ratio of 26.16, a PEG ratio of 2.48 and a beta of 1.22. Agilent Technologies, Inc. has a fifty-two week low of $106.55 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were given a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.